Healthcare - Biotechnology - NASDAQ - US
$ 59.69
-0.0837 %
$ 2.33 B
Market Cap
-26.53
P/E
Price Target
Average
1.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
27.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Longboard Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for LBPH of $60.3 , with forecasts ranging from a low of $36 to a high of $90 .
LBPH Lowest Price Target
Wall Street Target
36 USD
-39.69%
LBPH Average Price Target
Wall Street Target
60.3 USD
1.00%
LBPH Highest Price Target
Wall Street Target
90 USD
50.78%
REVENUE FORECAST
Revenue Forecast Chart LBPH
EBIT FORECAST
EBIT Forecast Chart LBPH
NET INCOME FORECAST
Net Income Chart LBPH